**T2 Biosystems Announces Amendments and Voting Results from Annual Meeting**Lexington, Massachusetts – T2 Biosystems, Inc. (NASDAQ: TTOO) recently disclosed significant updates from its recent Annual Meeting with stockholders held on December 30, 20

*

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read T2 Biosystems’s 8K filing here.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.